Grail

By Grail

GRAIL (an Illumina spinoff) is a genomics-based cancer diagnostics company that developed Galleri, a multi-cancer early detection (MCED) blood test that can screen for over 50 types of cancer from a single blood draw by detecting cell-free DNA methylation patterns associated with cancer, including cancers with no existing screening tests.

Grail Intelligence Room

See. Share. Shape.

Every post on social media is buried the next day. Not here. Signals become memory, and memory becomes intelligence.

Share your experience about Grail

Trending signal

Priority Health Launches 2 Cancer Support Solutions with Color Health, Grail

Does that match what you're seeing?

According to MedCity News

Human reality

What users are seeing.

Gathering

The first real accounts of Grail are still being gathered.

Tool intelligence

What HealthAratus understands

HealthAratus currently understands Grail through company records and external market activity.

Category
imaging_diagnostics

What HealthAratus is still learning

HealthAratus is beginning to understand Grail. As evidence and experience accumulate, what remains unclear will be stated here.

Category ranking

Imaging & Diagnostics

258+ tools observed

  1. 101Experian HealthDeveloping
  2. 102iCADDeveloping
  3. 103Definitive HealthcareDeveloping
  4. 104GrailDeveloping
  5. 105InterWell HealthDeveloping
  6. 106WispDeveloping
  7. 107Abbott CardiovascularDeveloping

Grail is ranked number 104 in Imaging & Diagnostics by HealthAratus Score). Rankings will change as more intelligence comes in, so follow Grail to see all changes.

See. Share. Shape.

The record ends here. The reality of Grail continues inside.

Enter the Reality Room